Impact of Sacubitril/Valsartan in Cardiac Reverse Remodeling in Ischemic vs. Nonischemic Cardiomyopathy
Omar Safdar(Thomas Jefferson University), Preethi Pirlamarla(Thomas Jefferson University), Ilya Danelich(AstraZeneca (South Korea)), Raquel Yotti Alvarez(Thomas Jefferson University), Sergio Cozzi(Thomas Jefferson University), Alec Vishnevsky(Thomas Jefferson University), Abbey Ervin(Thomas Jefferson University), Mahek Shah(Lehigh Valley Hospital-Pocono)
Cited by 2
Related Papers
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2015|55
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40
Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2016|29